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Summary
During biosynthesis onmodular polyketide synthases
(PKSs), chain extension intermediates are tethered
to acyl carrier protein (ACP) domains through phos-
phopantetheinyl prosthetic groups. Each ACP must
therefore interact with every other domain within the
module, and alsowith a downstream acceptor domain.
The nature of these interactions is key to our under-
standing of the topology and operation of these multi-
enzymes. Sequence analysis and homology modeling
implicates a potential helical region (helix II) on the
ACPs as a protein-protein interaction motif. Using
site-directed mutagenesis, we show that residues
along this putative helix lie at the interface between
the ACP and the phosphopantetheinyl transferase
that catalyzes its activation. Our results accord with
previous studies of discrete ACP proteins from fatty
acid and aromatic polyketide biosynthesis, suggest-
ing that helix II may also serve as a universal interac-
tion motif in modular PKSs.
Introduction
The multienzyme polyketide synthases (PKSs) biosyn-
thesize a diverse range of clinically valuable natural
products, including erythromycin A, epothilone, and
FK506 (Tacrolimus). PKSs function as molecular assem-
bly lines, as each round of chain extension and process-
ing is (usually) performed by a specific module within the
giant subunits [1–3]. Each module minimally contains
a ketosynthase (KS) domain that catalyzes carbon-
carbon bond formation, an acyl carrier protein (ACP) do-
main to which the growing chain is tethered, and an acyl
transferase (AT) domain that recruits the starter and ex-
tender units. Additional domains set the level of reduc-
tion of the biosynthetic intermediates and may comprise
ketoreductase (KR), dehydratase (DH), and enoyl reduc-
tase (ER) activities. Chain extension is typically termi-
nated by a thioesterase (TE) domain [4].
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act with all of the other domains within its module (Fig-
ure 1) (modeled after data contained in [5]). After chain
extension and reductive processing, the ACP also par-
ticipates in an acyl transfer reaction with a domain lo-
cated in a downstream module (either a KS [KSn+1] or
TE domain [Figure 1]). In the ‘‘double helical’’ model for
modular PKS architecture [5], each PKS multienzyme
is a homodimer, and the individual polypeptides are
twisted around each other. This arrangement places
the ACP at the spatial center of the module, where it
can access all of the other domains (Figure 1). This
mode of operation mirrors the essential role of ACP do-
mains in fatty acid biosynthesis and many metabolic
pathways [6], in which they engage in specific interac-
tions with multiple heterologous partners. In animals,
the component enzymes of fatty acid biosynthesis, in-
cluding the ACP, are joined by peptide linkages into
large (type I) multifunctional enzymes resembling a sin-
gle PKS module [7]. In plants and most bacteria, how-
ever, the fatty acid synthase (FAS) enzymes are present
as discrete proteins (type II) [8].
There is currently no structural information available
for type I PKS ACPs. However, the NMR or crystal struc-
tures of a number of type II ACPs from both FAS and
PKS systems [9–12], as well as the isolated ACP domain
from type I FAS of rat [13], have been solved. Although
the sequence identity among ACPs from such systems
is low (e.g., 14%–25% for the sequences shown in Fig-
ure 2), all solved ACP structures share a common topol-
ogy consisting of a four-a helix bundle [9]. Given the re-
semblance among ACP domains, modular PKS ACPs
are expected to have a similar global fold. Each ACP is
modified by posttranslational addition of the 40-phos-
phopantetheine moiety from CoA by a dedicated phos-
phopantetheinyl transferase (PPTase) enzyme [14],
which converts the inactive apo protein to the active
holo form. The active Ser, which accepts the 40-phos-
phopantetheine, is part of a highly-conserved DSL motif
at the base of helix II, on the surface of the protein. Co-
valent attachment of the acyl intermediates to the termi-
nal cysteamine thiol of the prosthetic group allows them
to be shepherded efficiently among the various active
sites within the PKS.
In this context, it is interesting to consider how each
PKS ACP can interact with all of the other domains within
its module, with the downstream KS or TE, and also
with a PPTase. In type II FAS and PKS systems, in which
catalysis is performed by a collection of individual en-
zymes, the ACP must share interfaces with all of its part-
ner domains in order to form the active complexes.
Structural, computational, and mutagenesis approaches
have identified helix II on type II FAS ACPs as a universal
‘‘recognition helix,’’ which binds to a common 3D surface
feature on its target enzymes [6, 15–17]. Modeling of the
interface between the ACP and KR domains from the
type II actinorhodin PKS similarly implicates helix II
[18]. However, given the low overall sequence homology
between ACP domains from FAS and PKS systems (Fig-
ure 2), PKS ACP domains may interact with partner
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dition, mutagenesis studies of the erythromycin modular
PKS (DEBS) [19] and the structurally related type I ani-
mal FAS [20] suggest that at least some of the catalytic
partners of each ACP domain are located on its own
Figure 1. Protein-Protein Interactions within PKS Modules
The ACP domain is the functional center of each PKS module, as it
interacts with every catalytic domain within the module during each
round of chain extension and reductive processing (modeled after
data contained in [5]). The specific interactions are as follows: (1)
between ACPn and ATn during loading of the starter/extender
unit; (2) between ACPn and KSn’ during chain extension (the apos-
trophe indicates that the KS domain lies on a separate polypeptide
from the ACP, within the PKS homodimer); (3) between ACPn and
KRn during ketoreduction (although interaction with KRn’ has not
been formally excluded); and (4) between ACPn and KSn+1 during
intermodular acyl transfer.polypeptide, within the overall homodimeric module
[5]. This arrangement may obviate the need for defined
protein-protein interfaces between the ACP and some
of its partner activities.
To begin to identify recognition features on type I ACP
domains, we chose to investigate the interaction be-
tween a representative ACP domain from DEBS and
the PPTase enzyme, SePptII, responsible for its post-
translational activation [21]. In addition, we used the
broad-specificity PPTase Sfp from Bacillus subtilis
[22], which has also been shown to recognize DEBS
ACP domains [21, 23]. Because the ACP and the PPTase
enzymes are not covalently attached within the PKS
multienzymes, they must share interfaces that can be
targeted by mutagenesis. This strategy is precedented
by experiments with the type II FAS ACP domains from
Escherichia coli and Vibrio harveyi [24–26] as well as
with various peptidyl carrier protein (PCP) domains
from the tyrocidine (Tyc) nonribosomal peptide synthe-
tase (NRPS) [27, 28]. In addition, NMR studies of individ-
ual ACP domains as both apo and holo proteins have
shown that the two forms have essentially identical
structures [12, 29]. This observation suggests that any
recognition motif identified for the apo domain will be
relevant to studies of the interaction between the holo
protein and its catalytic partners within the module.
Results
Identification of a Putative Recognition Motif
on DEBS ACPs
The sequence identities among modular PKS and type II
FAS ACPs are low (14%–25%, for the sequences shown
in Figure 2). However, the sequences are significantly
more homologous over the region that corresponds to
helix II, the recognition helix of the FAS ACPs (as high
as 47% pairwise identity between the FAS and PKS se-
quences shown in Figure 2). To evaluate whether thisFigure 2. Sequence Alignment of PKS ACP Domains
Multiple sequence alignment of the ACP domains from the closely related PKS systems from Saccharopolyspora erythraea (S. e.), Micromo-
nospora megalomicea (M. m.), and Aeromicrobium erythreum (A. e.) (all assemble the same polyketide core structure, 6-deoxyerythronolide
B) with the type II fatty acid ACP domains from Escherichia coli (E. c.), Vibrio harveyi (V. h.), and Bacillus subtilis (B. s.) was used to select
mutants within the helix II region of ACP6. The solid bar indicates the extent of helix II in FAS ACP domains as determined by structural analysis
[12]. Residues are numbered according to ACP6. The sequences were aligned with Clustal W [60], and the figure was produced by using
BoxShade 3.21 (http://www.ch.embnet.org/software/BOX_form.html).
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627Figure 3. Sequence Alignment and Homology Model of DEBS ACP4
(A) Sequence alignment used to build the model of ACP4.
(B) The homology model of ACP4, showing the predicted extent of helix II (residues S34–A47).portion of the modular PKS ACPs is also likely to be he-
lical, we constructed a homology model of ACP4 from
DEBS. The choice of ACP4 was arbitrary, as the level of
sequence identity among DEBS ACP domains (37%–
64% pairwise) shows that their overall structures are
similar [30, 31]. The sequence of ACP4 was submitted
to FUGUE [32] for both sequence and structural align-
ment. FUGUE identifies homologs of a query sequence
by using PSI-BLAST [33], from which it calculates a se-
quence profile. This sequence profile is then used to
screen the structural profile library within FUGUE for
potential structural homologs (see Experimental Proce-
dures). For fold assignment, the ACP4 sequence was
also submitted to the fold recognition server 3D-PSSM
[34–36]. Both programs identified the PCP domain
TycC3 as the preferred template for ACP4. Although
other candidate templates were obtained, none had a
sequence identity with ACP4 greater than 30%. The se-
quences of ACP4 and TycC3 were therefore aligned
with ClustalX and used for model building with MODEL-
LER [37]. The 32% sequence identity between ACP4 and
the template TycC3 PCP is at the lower end of what
is normally considered capable of producing a reliable
homology model [30, 31]. Therefore, we confined our
analysis to consider the overall fold and clear elements
of secondary structure. In the model (Figure 3), ACP4
consists of a distorted 4-a helix bundle, containing 3 ma-
jor helices (I, II, and IV) (9–14 residues), a shorter helix (III)
(6 residues), and a long loop region between helices I
and II (21 residues). Inspection of the model shows that
the predicted extent of helix II (residues 34–47) encom-
passes the region of highest similarity to the FAS ACP
domains (Figure 2) (although the locations of the helices
in ACP4 have only been identified through an in silico
experiment, for simplicity we will hereafter refer to the
region between residues 34 and 47 as helix II). Therefore,
both our sequence analysis and homology modeling
implicated helix II of PKS ACP domains as a potential
protein-protein recognition motif.
Selection of the Mutants for PPTase Interaction
Studies
To evaluate the role of helix II in protein-protein recogni-
tion, we chose to carry out site-directed mutagenesis ofDEBS ACP6, covalently linked to its downstream TE
partner. This didomain was first identified as a stable
fragment in limited proteolysis experiments of DEBS
multienzymes [38], and it can be purified in good yield
from E. coli using nickel affinity chromatography. The
putative helix II region of ACP6 was identified by se-
quence alignment with DEBS ACP4 and the FAS ACPs
(Figure 2). The following mutants were selected in order
to make the DEBS ACP6 more similar to the E. coli FAS
ACP: T40D, G43E, R45V, R45E, Q47A, Q49E, and
Q50E. Residues D37 and L39, which are more highly
conserved among ACPs, were both mutated to alanine.
A panel of double mutants, including T40D+R45V,
G43E+R45V, Q49E+R45V, and Q50E+R45V, was also
created. Although V42 and N46 may also function as
interface residues, the obvious mutants (such as to
alanine or charged residues) at these positions occur
naturally within other ACP domains of DEBS (Figure 2)
[39]. In addition, the alanine variants of T40, G43, Q49,
and Q50 are also present in alternative DEBS ACPs.
Although the mutagenesis strategy introduced many
nonconservative mutations (for example, changes in
charge on the residue), it was supported by three consid-
erations. First, the mutant residues are present in the
equivalent position within helix II of multiple FAS ACPs,
so we anticipated that the mutations would not have
a significant effect on the structure of the ACP6 domain.
Second, such mutations were expected to have a mea-
surable impact on the interaction between the ACP do-
main and the PPTases, should they occur at a critical
position within the interface. Finally, by mutating the
DEBS ACP6 domain toward that of FAS, we could evalu-
ate whether the altered ACPs would become substrates
for the PPTase which is native to the E. coli expression
host, whose recognition region (helix I) contains multiple
positively charged residues [26, 27]. A significant gain
of activity would enable the expression of holo PKS pro-
teins in E. coli without the need to coexpress a heterolo-
gous PPTase enzyme [21]. As proof of principle, it has
been shown that reversing the charge on a single residue
within the region of the TycC3 PCP corresponding to
helix II (K47D, equivalent to residue T40 in the PKS
ACP6) is sufficient to make the mutant PCP a substrate
for the E. coli PPTase [27, 28]. The double mutants of
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628Figure 4. Secondary Structure Analysis of the Wild-Type ACP6-TE Domain and Mutants
(A) Infrared spectra obtained of the wild-type ACP6-TE and a selection of mutants in the amide I region (inset, the deconvoluted spectrum of
the wild-type domain). The spectra have been baseline corrected.
(B) Melting temperatures (TM) obtained for the wild-type ACP6-TE and all mutants.
(C) Percentages of a helices and b sheets determined by deconvolution of the CD spectra of wild-type ACP6-TE and all mutants. The bars
indicate the standard deviation from the mean value for each mutant, as determined by alternative deconvolution methods. The range of pre-
dicted values for the wild-type didomain is shown relative to those of the mutants (dotted lines).ACP6 were particularly interesting, as previous studies
have shown that the greater the resemblance of the sub-
strate to the FAS ACP within helix II, the more efficiently
it is recognized by the E. coli PPTase [27]. The overall
charge on the proteins is also likely to be important for
the interaction, as the FAS ACP has a pI of 3.81 and its
PPTase partner has a pI of 9.3. The double mutants of
ACP6 had pI values (4.63–4.66) that were significantly
lower than the wild-type value (5.42).
Cloning and Expression of the ACP6-TE Mutants
and Expression of the PPTase Enzymes
Site-directed mutagenesis was carried out on the ACP6-
TE gene by QuickChange mutagenesis (details on the
construction of this expression vector have been re-
ported previously [21]). The mutant plasmids were se-
quenced between naturally occurring SacI and DraIII
sites within the ACP gene, and then the correct SacI-
DraIII fragments were excised and cloned back into
the unmutated parent vector. The mutated and wild-
type ACP6-TE didomains were expressed in E. coli
BL21-CodonPlus-RP cells and purified in a single step
using nickel affinity chromatography. All of the mutant
proteins were expressed at similar levels to wild-type
(5–7 mg ACP-TE/l of culture), with the exception of
D37A (1.4-fold lower yield), suggesting that the majority
of the mutations had not significantly affected the
expression and native folding of the proteins. The mas-
ses of the purified proteins were determined by high-
pressure liquid chromatography-mass spectrometry
(HPLC-MS), which revealed that all of the proteins were
in their unmodified, apo forms. Evidently, the mutationsintroduced into the ACP6 domain were insufficient to
enable its recognition by the E. coli PPTase enzyme.
The PPTases SePptII and Sfp were expressed and pu-
rified as described previously [21], although SePptII was
obtained at an improved level of purity. The presence of
residual contaminating proteins in the preparation of
SePptII was not expected to affect the rates of phospho-
pantetheinylation in vitro, as none of the native E. coli
proteins can perform the reaction in vivo.
Structural Analysis of the Wild-Type and Mutant
ACP6-TE Didomains
In principle, the interaction between the PPTase and the
substrate ACPs could be altered by structural changes
to the ACP domain resulting from the mutations. There-
fore, to evaluate the structural integrity of the mutants,
thin films of hydrated wild-type and mutant ACP do-
mains were analyzed by attenuated total reflection
(ATR) infrared spectroscopy. Secondary structure anal-
ysis was then performed by Gaussian curve fitting of the
resolution-enhanced spectra [40, 41]. This analysis re-
vealed no significant differences in secondary structure
among the mutants (Figure 4A).
To strengthen this result, far-UV circular dichroism
spectra (CD) and melting temperatures (TM) (Figure 4B)
were obtained of the wild-type and each of the mutant
ACP-TE didomains. Deconvolution of the spectra was
carried out with Selcon3 and CDSSTR [42] by using
the Dichroweb interface [43]. The percentages of a heli-
ces and b sheets for each of the proteins were then cal-
culated by using the combined results from both Sel-
con3 and CDSSTR (reference sets 3 and 6) (Figure 4C).
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cantly altered by the mutation(s) when the average value
for the percentages of a helices or b sheets for a partic-
ular mutant was greater than one standard deviation
from that of the wild-type protein (wild-type: 41.6%
a-helix; 13.6 % b sheet). None of the proteins showed
more than a 4% change in TM (Figure 4B), suggesting
that their overall stability was unaffected by the muta-
tions. However, the CD spectra of L39A, T40D, and
R45E showed statistically significant increases in the
content of b sheets, although the proportion of a helix
was not substantially different (Figure 4C).
This type of analysis does not reveal any information
on changes to the tertiary structure of the proteins in
the region of the mutation. However, it has recently
been shown that a largely a-helical 11 residue peptide
(the ‘‘ybbR tag’’) incorporating the conserved helix II
DSL motif is efficiently recognized by Sfp [44]. This result
suggests that the a-helical scaffold for the active site
serine is the critical structural element for the phospho-
pantetheinyl transfer reaction. Our results from both IR
and CD indicate that this region was essentially un-
changed by the mutations, though it is impossible to
rule out very subtle structural alterations.
Design of the Phosphopantetheinyl Transfer Assay
We anticipated that mutations to helix II could alter
the rate of the phosphopantetheinyl transfer reaction
through effects on the formation or stability of the
ACP-PPTase complex as well as through effects on
the catalytic step in which the ACP active site serine is
modified. In either case, changes to the rate upon muta-
tion of a specific amino acid would demonstrate that the
residue in question is involved in the interaction between
the enzymes, and thus help to define the protein-protein
interface.
Structural and mutational analysis of Sfp has identi-
fied the loop between b4 and a5 (residues T111–S124)
as the region of the enzyme that binds its native PCP
substrate [45]. Among these residues, K112, E117, and
K120 are proposed to engage in electrostatic and hydro-
gen bonding interactions with the PCP. Inspection of se-
quence alignments of PPTase enzymes (Figure 5) sug-
gests that the corresponding residues in SePptII are
E110, G115, and D118. By this analysis, the charges of
the putative recognition residues in SePptII are reversed
at two positions, while a neutral residue replaces a
charged residue at the third. We could therefore pre-
dict that if helix II lies at the interface with the PPTase,
then introducing negatively charged residues should
have a deleterious effect on the ability of the ACP to as-
sociate with SePptII and should therefore lower the rate
of phosphopantetheine transfer. In contrast, the same
mutations should increase the rate of reaction by Sfp.
Such data would provide additional evidence that the
mutations in helix II had affected the interaction between
the proteins, and had not simply introduced structural
defects into the ACP6-TE didomain.
In previous experiments to evaluate phosphopante-
theinylation of mutant carrier protein (CP) domains [14,
22, 28, 45–47], the extent of phosphopantetheine trans-
fer has been measured by the rate at which radioactivity
is incorporated from 3H-labeled coenzyme A into the
substrate ACP or PCP. This method relies on precipitat-ing the CP with trichloroacetic acid, prior to analysis by
liquid scintillation counting and/or autoradiography.
However, precipitation has been shown to introduce
significant variability into the data, particularly with the
low concentrations of substrate (< 1 mM) required for ki-
netic analysis [46, 48]. As an alternative, we investigated
HPLC-MS analysis of the modified ACP6-TE in the ab-
sence of precipitation. Our experiments showed that
the reaction could be stopped at various time points
by the addition of 4% glacial acetic acid. Direct HPLC-
MS analysis of the quenched samples could then be
used to quantify the relative amounts of apo and holo
proteins in the samples, yielding an initial reaction rate
(Figure 6). Control reactions in which wild-type ACP6-
TE was incubated with CoA and SePptII in buffer that
had been preacidified showed no detectable phospho-
pantetheine transfer.
To evaluate the utility of this method for carrying out
kinetic analysis, we initially determined the rate of phos-
phopantetheinylation of the wild-type protein and the
R45V mutant. Here, we selected a range of concentra-
tions set by the detection limit of the HPLC-MS instru-
ment (1.5, 3.1, 5.2, and 10 mM). This analysis revealed
that SePptII is inhibited by its substrate, ACP6-TE (the
rate of reaction at 10.4 mM ACP6-TE was reduced by
5-fold relative to that at 1.5 mM). The R43V mutant also
exhibited inhibition kinetics, though to a lesser extent
(2-fold rate reduction over the same range of concentra-
tions). PPTase substrate inhibition has been observed
previously in experiments with FAS ACPs from E. coli
and Streptococcus pneumoniae [46, 48, 49], and it
may result from the presence of multiple apo ACP con-
formers or improper binding of the ACP to the active
Figure 5. Multiple Alignment of PPTase Domains
The CP recognition region determined for Sfp from Bacillus subtilis
(B. s.) is indicated by a solid bar, and three specific residues impli-
cated by site-directed mutagenesis in electrostatic interactions
with the substrate are indicated by boxes. The corresponding
residues in SePptII are indicated (boxes). Abbreviations are: A. e.,
Aeromicrobium erythreum; S. a., Streptomyces avermitilis; S. c.,
Streptomyces coelicolor; S. an., Streptomyces antibioticus Tu
6040; S. v., Streptomyces verticillus; Sac. e., Saccharopolyspora
erythraea; M. t., Mycobacterium tuberculosis; B. p., Bacillus pumi-
lus; S. m., Streptomyces murayamaensis; S. sp., Streptomyces
species PGA64; A. sp., Anabena species; B. a., Bacillus anthracis.
The sequences were aligned with Clustal W [60], and the figure was
produced by using BoxShade 3.21 (http://www.ch.embnet.org/
software/BOX_form.html).
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Samples (100 ml) of an assay mixture containing wild-type ACP6-TE and SePptII were removed after 4, 7, and 10 min, quenched with 4 ml glacial
acetic acid, and snap frozen in liquid nitrogen. The end point of the reaction was determined from a 2 hr incubation. All of the samples were
analyzed by high-performance liquid-chromatography mass spectrometry (HPLC-MS) to determine the relative proportion of apo (MW 38965/6
Da) and holo (39305/6 Da) protein at each time point, by comparison of the corresponding peak heights.site on the PPTase [46]. In contrast to SePptII, Sfp
showed significantly less inhibition with increasing con-
centrations of ACP6-TE, suggesting that its KI value for
the substrate is significantly higher than its KM. In either
case, it is unlikely that the ACP6-TE concentrations are
saturating, as the measured KM values for natural CP
substrates are in the range 0.2–5 mM, and those for het-
erologous CPs are typically higher [28, 45, 47].
As the substrate inhibition precluded a straightforward
determination of the Michaelis constants, we instead
compared the initial rates of phosphopantetheinylation
of the wild-type ACP6-TE didomain and mutants when
present at the same concentration (3.1 mM). This con-
centration represents the minimum amount of protein
required to yield a clear signal above background by
HPLC-MS, and it is also not significantly inhibitory to
SePptII. Based on initial studies with the wild-type
ACP6-TE, concentrations of SePptII (3.1 nM) and Sfp
(15 or 31 nM, in a particular assay) were selected so
that the rates of reaction with the two PPTases for all
mutants were similar. Incubations were carried out un-
der conditions reported earlier [21]: NaPi (50 mM for
Sfp [pH 6] or SePptII [pH 7]), MgCl2 (10 mM), DTT
(5 mM), CoASH (500 mM–1 mM) in a total volume of
300 ml. The PPTase enzymes were added, and then three
aliquots (100 ml) of the reaction were removed at various
times within the linear portion of the rate profile (as de-
termined by initial studies), quenched by the addition
of acetic acid (4 ml), and snap frozen in liquid nitrogen.
As the reaction did not always go to completion, a reac-
tion was carried out in every case to determine the end
point of phosphopantetheinylation, typically by incubat-
ing for 2 hr (a substantial decrease in the stability of
ACP6-TE was observed upon longer incubations). Even
after 6 hr, the reactions with mutants L39A and R45E
were incomplete; thus, the end point reached was taken
as 100% modification. All samples and controls were
analyzed by HPLC-MS, and the relative proportions of
apo and holo ACP6-TE at each time point were deter-
mined from the corresponding peak heights (Figure 6).
The rates of reaction were then calculated by linear re-
gression from the individual time points, incorporating
a correction for the final extent of phosphopantetheiny-
lation, if necessary.In order that the results from each protein could be
compared, the assays on the ACP6-TE and each of the
mutants were carried out simultaneously with identical
samples of the PPTase enzymes. Due to the technical
difficulty of analyzing the large number of samples gen-
erated in these experiments by HPLC-MS, the initial
rates could only be determined twice with all of the mu-
tants; however, in the majority of cases, rates could be
determined three times. However, additional experi-
ments with a subset of the mutants (data not shown)
were always consistent with the trends observed when
all of the mutants were assayed together.
Mutation of Helix II Has Opposite Effects on
Phosphopantetheinylation by SePptII and Sfp
The relative rates of phosphopantetheinylation of the
wild-type ACP6-TE and the mutants by both SePptII
and Sfp are shown in Table 1. In deriving these results,
the average value for the initial rate for each mutant
has been compared to that of the wild-type protein.
The data show that changes to the rate of the reaction
with both PPTase enzymes were observed for mutations
along the length of helix II. Our results therefore provide
strong evidence that helix II serves as a protein-protein
interaction interface on the ACP domain.
The reactivity of the G43E and Q49E mutants with
SePptII was essentially unchanged. Of the remaining
mutants, T40D and Q47A yielded slight increases in
rate; L39A, R45V/E, and Q50E had a deleterious effect;
and the D37A mutant yielded no detectable reaction.
D37 sits within the highly conserved ‘‘DSL’’ motif at the
amino terminus of helix II, consistent with it playing an
essential role in the reactivity of the CP domains. In the
cocrystal structure of the FAS ACP from B. subtilis with
its partner PPTase, AcpS, the corresponding Asp resi-
dues participate in an essential salt bridge with a con-
served Arg residue on AcpS, which serves to correctly
orient the active site Ser for modification [26]. In further
support of our result, mutation of the corresponding
Asp to Cys in the ACP from E. coli FAS completely abol-
ished the phosphopantetheinyl transfer reaction [6].
Mutation here of the leucine within the DSL motif to
alanine also markedly lowered the reaction rate (ca. 13-
fold). In the ACP/AcpS cocrystal structure, the leucine
Modular PKS ACP Protein-Protein Interaction Motif
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Protein
Reaction with SePptII
(Relative to Wild-Type)
Trends in Reactivity
with SePptII
Reaction with Sfp
(Relative to Wild-Type)
Trends in Reactivity
with Sfp
ACP6-TE 1 1
D37A No reaction N.A. No reaction N.A.
L39A 0.08 (0.09, 0.07)a YY 0.020 (0.023, 0.017)a YY
T40D 1.4 6 0.1 [ 0.46 6 0.05 Y
G43E 0.9 6 0.1 2 1.30 6 0.07 [
R45V 0.56 (0.62, 0.51)a Y 4.6 6 0.3 [[
R45E 0.038 (0.032, 0.043)a YY 0.02b YY
Q47A 1.4 (1.3, 1.5)a [ 1.4 (1.2, 1.5)a [
Q49E 0.92 6 0.04 — 1.7 6 0.1 [
Q50E 0.74 6 0.08 Y 1.2 (1.1, 1.3)a [
T40D+R45V 0.80 6 0.08 Y 4.9 6 0.2 [[
G43E+R54V 0.80 6 0.08 Y 5.4 6 0.4 [[
Q49E+R45V 0.60 6 0.06 Y 5.2 6 0.3 [[
Q50E+R45V 0.59 6 0.04 Y 4.8 6 0.5 [[
For each mutant, the initial rates obtained from multiple experiments (at least two) with each PPTase enzyme were averaged, and then compared
to the average initial rate for the wild-type ACP6-TE. Data are reported as mean 6 SEM.
a Mean values obtained from two independent measurements (shown in parentheses).
b Only a single experiment with this mutant yielded useable data.participates in an essential hydrophobic interaction with
the AcpS [26], which may not be possible with a smaller
Ala residue. However, our CD analysis revealed changes
to the secondary structure of L39A, which might also
account for the very significant decrease in rate. Of the
remaining mutants, those involving residue R45 pro-
duced the most significant reductions in transfer effi-
ciency, when present as a single mutant or within the
context of double mutants. This residue is strictly con-
served among ACPs from many modular PKS systems,
in contrast to other residues within helix II (Figure 2;
Figure S1, see the Supplemental Data available with
this article online). The reductions in rate observed
with this mutant cannot be attributed to an increase in
substrate inhibition, as R45V gave a reduced degree of
inhibition relative to wild-type over a range of concentra-
tions. The activity of R45E was 27-fold lower than that of
wild-type, although this decrease in rate could also be
due to structural defects in the mutant protein. CD anal-
ysis of T40D also showed that the secondary structure
was significantly altered, making the increase in reactiv-
ity seen with this mutant difficult to interpret.
Table 1 shows that Sfp also failed to modify the D37A
mutant, and that its rate of reaction with L39A was like-
wise very slow (50-fold reduced relative to wild-type).
Again, interpretation of these results is complicated by
the observed structural defects in L39A. However, the
data suggest that the DSL motif makes similar, critical in-
teractions with both Sfp and SePptII. For the remaining
mutants, the trends in reactivity with Sfp are essentially
opposite to those with SePptII, as the majority produced
a substantial increase in the reaction rate. Mutations
such as G43E, Q49E, and Q50E, which introduced nega-
tive charge into helix II, resulted in a 1.3- to 1.7-fold in-
crease in reactivity. Mutation of the R45 residue to valine
in any context increased the rate of reaction by over 4.5-
fold. The double mutants, in which R45V was combined
with mutations that introduced negative charge along
the length of the helix, yielded the highest overall in-
creases in rate (up to 5.4-fold). This finding is relevant
to the design of optimized small peptide motifs (such
as the ybbR tag) for labeling by Sfp [44].The differences in reactivity between SePptII and Sfp
with the helix II mutants were exactly as predicted from
our analysis of their putative CP binding regions. The po-
tential recognition region of SePptII contains two nega-
tively charged residues, E110 and D118. Therefore, mu-
tations that introduced negatively charged residues into
helix II were expected to adversely affect the formation
or stability of the ACP-PPTase complex. Replacing
G43 with glutamate, however, had very little effect on
the rate, consistent with the fact that this position is oc-
cupied by E and D in other DEBS ACPs (Figure 2). The
arginine residue at position 45 of the ACP could engage
in attractive ionic or hydrogen bonding interactions with
the residues on SePptII. Thus, removing the charge was
expected to lower the rate of phosphopantetheine trans-
fer. In contrast to SePptII, the recognition loop of Sfp in-
corporates two positively charged residues, K112 and
K120, at the equivalent positions to E110 and D118. Con-
sequently, mutations that introduced negative charge
into ACP6 helix II or removed a repulsive interaction be-
tween R45 and the two lysine residues were anticipated
to promote the association of the proteins. Although the
R45E mutant could, in principle, form new attractive in-
teractions with K112 and K120, the structural changes
to the mutant as observed by CD may account for its
extremely low reactivity (50-fold reduced relative to
wild-type).
Discussion
Reduced polyketides, such as erythromycin A, are as-
sembled by multistep catalytic processes on modular
PKSs. Throughout the biosynthesis, the chain-exten-
sion intermediates remain tethered to the phosphopan-
tetheine swinging arm of the integral ACP domains. This
mode of operation requires that the ACP interact with all
of the other domains within each module, but also with
a catalytic domain (either a KS or TE) located in the mod-
ule downstream. Although the assembly process re-
quires a specific sequence of catalytic events, the inter-
actions that the ACP domain makes with the catalytic
activities need not occur in any particular order. For
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the reductive elements when bearing an extender unit
such as malonate or methylmalonate instead of the
newly extended polyketide chain, catalysis could not
occur. After the chain is extended, the ACP could still
engage in random, nonproductive interactions with the
reductive loop activities without deleterious effects, as
the DH domain can only operate after the KR has per-
formed its reaction, and the ER domain can operate
only after catalysis by the DH. In fact, the only ‘‘choice’’
the ACP makes is between interactions with enzymes
within its own module and transfer of the group attached
to its swinging arm to a domain in the next module. Ac-
cording to this model, there are only two critical inter-
faces within the PKS. The first is between the ACP do-
main and the KS activity within its own module, such
that the geometric and stereoelectronic requirements
of the condensation reaction can be satisfied. The sec-
ond is with the acceptor domain in the downstream mod-
ule, so that chain transfer occurs only at the appropriate
time. Interactions with the reductive elements could
occur at random, facilitated only by the proximity of the
domains to the ACP by virtue of their covalent linkage
into a multienzyme complex. This view contrasts mark-
edly with the situation in type II FAS and PKS systems,
in which the ACP must share defined, though transient,
interaction interfaces with all of its catalytic partners.
In an alternative view [16], however, the interprotein
interactions may be more strictly regulated. Subtle con-
formational changes on the ACP induced by interactions
with the various forms of the chain-extension intermedi-
ate could expose new protein recognition sites on the
ACP, making the CP a better substrate for one or the
other of the catalytic domains at a particular point in
the chain-extension process. In the absence of any
high-resolution structural information on PKS modules,
we cannot at present discriminate between these two
models. Although encouragingly a 4.5 A˚ X-ray crystal
structure of the related type I animal FAS was recently
reported [50], it is striking that the position of the ACP
is not at all defined. This observation underlines the im-
portance of obtaining independent information on the
specific interactions between the ACP and its partner
domains, as a complement to structural efforts.
We aimed, therefore, to identify and characterize a
protein-protein interaction motif on a typical ACP do-
main derived from a modular PKS. Multiple sequence
alignment (Figure S1) reveals that ACPs from a range
of modular PKS systems are highly similar; thus, each
ACP is representative of a large group of domains. Al-
though the overall sequence identity between PKS and
type II FAS ACP domains is relatively low, the sequences
show significantly higher homology over a 14-residue
stretch, which corresponds to helix II in the FAS ACPs
(Figure 2). In our homology model of an ACP domain
from the DEBS PKS, this region also forms the second
a helix within the overall four-helix bundle. Crucially, he-
lix II from FAS ACP domains has previously been impli-
cated as a universal ‘‘recognition’’ helix, suggesting that
it may provide the same function for modular PKS ACPs.
To test the role of this potential helix, we investigated
the interaction between DEBS ACP6 and the discrete
enzymes SePptII and Sfp, which catalyze phosphopan-
tetheine transfer. Mutations at the interface wereexpected to have a detectable effect on the rate of holo
protein formation. In addition, our results could be com-
pared directly to data obtained with type II ACP domains
and their PPTase partners [24–26]. Our analysis by
HPLC-MS showed that mutations along the length of
the putative ACP helix II produced changes to the rate
of phosphopantetheinylation by both SePptII and Sfp,
supporting a role for this region as an important protein
recognition element. The highly conserved DSL motif at
the N terminus of helix II appears to be critical for the
reaction with both enzymes, with R45 in the middle of
the helix also contributing significantly. In addition, the
overall charge on the helix seems to be an important
determinant of the interaction efficiency with Sfp.
It is difficult to design suitable controls for site-di-
rected mutations in the absence of atomic resolution
structures. However, the results of our experiments pro-
vide us with internal controls as to the effects of the
mutations on both the structure and reactivity of ACP6.
Two of the mutations (G43E and Q49E) gave essentially
no change in the reaction with PPTase SePptII, demon-
strating that mutation alone does not alter the rate. Our
confidence in the structural integrity of the mutants
comes not only from the careful biophysical analysis
by IR and CD [15, 16, 24], but also from the fact that
the mutations produced opposite trends in reactivity
with the two PPTase enzymes. Significantly, we could
rationalize our results on the basis of charge differences
in the region of the PPTase proteins expected to recog-
nize their CP substrates. Such behavior would not be
expected if the mutations had significantly altered the
folding of the ACP domain.
Because amino acids within the putative helix II region
are well conserved among PKS ACP domains (Figure S1),
it is likely that PPTase-ACP interactions in type I systems
are mediated, at least in part, by residues within this
sequence. In contrast, the modeled interface between
DEBS ACP6 and the TE (to which it is covalently attached
by a 65-residue linker [51]) is not predicted to involve
helix II, except for the aspartate residue adjacent to the
active site serine. In the ACP6-TE model, the interface
is formed instead between residues on the third helix of
ACP6 (E64, H64, and P65) that contact four arginines on
the TE [4]. Experiments to evaluate the interaction be-
tween ACP6 and the TE, as well as with its other partner
domains within each module, are currently underway.
Significance
Genetic alteration of the modular or type I PKSs holds
promise for generating modified polyketide products
for use in drug discovery. However, a significant stum-
bling block to routine engineering remains the lack
of detailed structural and mechanistic information on
these gigantic multienzymes. For example, it is not
known how the correct sequence of reduction reac-
tions is accomplished within a module after chain ex-
tension, as each reduction event competes directly
with transfer of the polyketide chain to the subsequent
module. In engineered hybrid systems, aberrant chain
transfer has been observed prior to full reductive pro-
cessing. The ACP domain within each module must
play a critical role in the ‘‘choice’’ of these alternative
fates, as it shuttles the intermediate among all of the
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to the downstream module. Detailed knowledge of the
interaction interfaces that the ACP shares with all of
its partner activities will provide significant insight
into the three-dimensional relationship among the
domains that facilitates their interactions, as well as
illuminate aspects of interaction dynamics and regula-
tion. Sequence analysis and homologymodeling iden-
tify a potential helical region in modular PKS ACP do-
mains that might serve as an interaction motif. Data
obtained from site-directed mutagenesis of a model
ACP6-thioesterase didomain comprise, to our knowl-
edge, the first evidence for a role for this helix at the
ACP-PPTase interface. Our results, which are fully
consistent with previous studies on discrete ACP do-
mains from fatty acid and type II PKS systems, set
the stage for identifying and characterizing all of the
ACP interprotein interfaces.
Experimental Procedures
Abbreviations
The following abbreviations are used in this article: PKS, polyketide
synthase; ACP, acyl carrier protein; KS, ketosynthase; AT, acyltrans-
ferase; KR, ketoreductase; DH, dehydratase; ER, enoyl reductase;
TE, thioesterase; FAS, fatty acid synthase; DEBS, 6-doexyerythrono-
lide B synthase; PPTase, 40-phosphopantetheinyl transferase; SePp-
tII, PPTase from Saccharopolyspora erythraea involved in erythro-
mycin biosynthesis; Sfp, PPTase from Bacillus subtilis involved in
surfactin biosynthesis; PCP, peptidyl carrier protein; Tyc, tyrocidine;
NRPS, non-ribosomal peptide synthetase; CP, carrier protein.
Materials and General Methods
All chemicals were reagent grade or better. Ampicillin, carbenicillin,
RNase, DNase, coenzyme A, MgCl2, and Bradford Reagent were
purchased from Sigma. IPTG (isopropyl-b-D-thiogalactopyrano-
side), dithiothreitol (DTT), and chloramphenicol were obtained
from Melford Laboratories, Ltd. NaH2PO4 and NaCl were purchased
from Fischer Chemicals. Complete protease inhibitor cocktail
tablets were obtained from Roche Molecular Biochemicals. Nickel
nitrolotriacetic acid (NTA) resin was obtained from Qiagen. PD-10
columns were purchased from Amersham-Pharmacia. Escherichia
coli BL21-CodonPlus-RP was obtained from Stratagene. Standard
procedures for DNA isolation and manipulation were performed as
described previously [52]. Restriction endonucleases and T4 DNA
ligase were obtained from New England Biolabs. Isolation of DNA
fragments from agarose gel and purification of PCR products were
carried out with the NucleoSpin 2 in 1 Extract kit (Macherey-Nagel,
Du¨ren, Germany). Mutagenic PCR was carried out by using the
QuickChange Multi Site-Directed Mutagenesis Kit (Stratagene),
while standard PCR reactions were performed with Pfu polymerase
(Stratagene); reactions were performed on a programmable Robo
Cycler Gradient 96 (Stratagene). Synthetic oligonucleotides were
purchased from TAG Newcastle, and automated DNA sequencing
was carried out on double-stranded DNA templates by using an
automated ABI Prism 3700 DNA Analyser (Applied Biosystems).
Amino acid analysis was performed by the Protein & Nucleic Acid
Chemistry Facility (PNAC) in the Department of Biochemistry, Uni-
versity of Cambridge.
Homology Modeling of DEBS ACP4
The sequence of erythromycin ACP4 was submitted to FUGUE [32]
for both sequence alignment and fold assignment. FUGUE is a pro-
gram developed to recognize even distant homologs of known
structures [53]. Given a single query sequence, FUGUE runs PSI-
BLAST [33] to perform a search against the NCBI nonredundant se-
quence database and collects sequence homologs. The alignment
produced by PSI-BLAST is then used to calculate a sequence pro-
file, which describes the observed amino acid distribution at each
position of the query sequences. FUGUE then compares this
sequence profile against each structural profile in its profile libraryderived from the HOMSTRAD database [54]. A structural profile con-
sists of two matrices: a scoring matrix and a gap penalty matrix. The
key feature of FUGUE is to calculate both matrices not only accord-
ing to the amino acid sequence information, but also to environ-
ment-specific substitution tables and structure-dependent gap pen-
alties. Therefore, scores for amino acid matching and insertions/
deletions are evaluated not only on the basis of sequence similarity,
but also on the local environment of each amino acid residue in
a known structure. Based on the compatibility between the se-
quence profile and the structural profiles, FUGUE produces a list
of potential homologs and alignments. In addition to FUGUE,
a fold recognition server (3D-PSSM) [34–36] was also used to iden-
tify the closest structural homologs. Both servers identified the PCP
TycC3 (pdb code: 1DNY) from the Tyc NRPS, with 32% sequence
identity, as the most suitable structural homolog. The sequences
of ACP4 and TycC3 PCP were aligned with ClustalX and used for
model building with MODELLER. The model was then improved by
using the loop-building programs RAPPER [55] and CODA [56]. Final
energy and structure minimization were performed by using the
SYBYL (Tripos, Inc., St. Louis, MO, USA) force field. The model
was then validated by PROCHECK [57], VERIFY3D [58], and by
visual inspection with three-dimensional graphics software. The re-
sults from all of these programs revealed that the ACP4 model did
not require further modification.
Site-Directed Mutagenesis of pACP-TEHis
Plasmid pACP-TEHis [21] was mutated by QuickChange mutagene-
sis according to the manufacturer’s instructions (Stratagene) by
using the following mutagenic primers (the modified sequence is
underlined; only the sense primer is shown): D37A (50-CGAGCTC
GGCTTCGCGTCGCTGACCGCGGTCG-30); L39A (50-CGGCTTCGAC
TCGGCGACCGCGGTCGGGCTGC-30); T40D (50-CTTCGACTCGCTG
GACGCGGTCGGGCTG-30); G43E (50-GACCGCGGTCGAGCTGCGC
AACCA-30); R45V (50-CGCGGTCGGGCTGGTGAACCAGCTCCAGCA
GG-30); R45E (50-CGCGGTCGGGCTGGAGAACCAGCTCCAGCAGG-
30); Q47A (50-CGGGCTGCGCAACGCGCTCCAGCAGGCCACCG-30);
Q49E (50-GCAACCAGCTCGAGCAGGCCACCG-30); Q50E (50-ACCA
GCTCCAGGAGGCCACCGGGC-30). The double mutants were de-
rived from the corresponding single mutants T40D, G43E, Q49E, and
Q50E by using the following mutagenic primers: T40D+R45V (50-
CGCGGTCGGGCTGGTGAACCAGCTCCAGCAGG-30); G43E+R45V
(50-CGCGGTCGAGCTGGTGACCGCTCCAGCAGG-30); Q49E+R45V
(50-CGCGGTCGGGCTGGTGAACCAGCTCGAGCAGG-30); Q50E+R53V
(50-CGCGGTCGGGCTGGTGAACCAGCTCCAGGAGG-30). The mu-
tant plasmids were then sequenced between naturally occurring
SacI and DraIII sites within the ACP-TE gene, and then the correct
sequences were excised as SacI-DraIII fragments and cloned into
unmutated pACP-TEHis previously digested with SacI and DraIII.
Expression and Purification of Wild-Type and Mutant
ACP6-TE Didomains
BL21-CodonPlus-RP cells were transformed with the plasmids con-
taining the wild-type and mutant ACP6-TE genes. Cultures were
grown in LB medium (500 ml) supplemented with carbenicillin
(50 mg/ml) and chloramphenicol (34 mg/ml) to an OD600 of >0.6, and
induced with IPTG (1.0 mM); expression was carried out at 30ºC or
37ºC for 3.5–4.5 hr, and then the cells were harvested by centrifuga-
tion and frozen at 220ºC. The cell pellets were resuspended in
chilled lysis buffer (5 mM imidazole, 50 mM NaH2PO4 [pH 8], 300
mM NaCl, 20% glycerol), containing protease inhibitor tablets, and
trace DNase and RNase. Cells were ruptured by sonication (Misonix,
Inc.), and the suspension was clarified by centrifugation at 21,0003
g for 30 min. The lysates were incubated with 500 ml Ni-NTA resin
and incubated at 4ºC forw1 hr. The resin was then washed stepwise
with lysis buffer containing 5, 10, and 20 mM imidazole, and then the
protein was eluted into lysis buffer containing 250 mM imidazole
(hereafter referred to as elution buffer). The proteins were aliquoted,
flash frozen in liquid nitrogen, and stored at 280ºC. By Bradford
and amino acid analysis, typical yields were 5–7 mg ACP-TE/l of cul-
ture. The molecular weight of each of the purified proteins was
obtained by high-performance liquid chromatography-mass spec-
trometry (HPLC-MS) on a Vydac Protein C4 column (30%–65% ace-
tonitrile/0.1% trifluoroacetic acid over 35 min) on a ThermoFinigan
LCQ.
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A plasmid containing the gene for Sfp was a kind gift from Y. Li [59].
The Sfp expression vector and pKJW152 containing the gene for
SePptII [21] were used to transform BL21-CodonPlus-RP cells.
Cultures were grown in LB medium (500 ml) supplemented with
kanamycin (30 mg/ml) and chloramphenicol (34 mg/ml) to an OD600
of >0.6, and were then induced with IPTG (0.1 mM [SePptII] and
0.2 mM [Sfp]); expression was carried out at 16ºC218ºC overnight,
and then the cells were harvested by centrifugation and frozen
at 220ºC. Cells were ruptured by sonication (Misonix, Inc.), and
the suspension was clarified by centrifugation at 21,000 3 g for
30 min. The lysates were incubated with 500 ml Ni-NTA resin and in-
cubated at 4ºC forw1 hr. The resin was then washed stepwise with
lysis buffer containing 5, 10, and 20 mM imidazole, and then the
protein was eluted into lysis buffer containing 250 mM imidazole.
The proteins were aliquoted, flash frozen in liquid nitrogen, and
stored at 280ºC.
Infrared Analysis of the Wild-Type and Mutant
ACP6-TE Didomains
Attenuated total reflection (ATR) infrared spectra were recorded at
room temperature on a Bruker Equinox 55 FTIR spectrometer equip-
ped with a liquid nitrogen-cooled MCT (mercury cadmium telluride)
detector. The sample compartment was continuously purged with
dry air. For each sample, 256 interferograms were collected at
a spectral resolution of 2/cm. Thin films of hydrated wild-type and
mutant ACP-TE were obtained by depositing 10 ml sample (in elution
buffer) on the crystal of a BioATRCell II setup (Bruker) and subse-
quent removal of excess water under a gentle N2 flow. Elution buffer
dried to the crystal was used as a background spectrum. Secondary
structure analysis [40] was done by Gaussian curve fitting of the res-
olution-enhanced spectra (by using GRAMS/AI.7, Thermo Galactic).
Second derivatives of the amide I band spectra were produced to
determine the localization of the different spectral components.
Resolution enhancement was achieved by Fourier self-deconvolu-
tion by using a band-narrowing parameter (g) of 10 and a Bessel
smoothing function. Band assignments were made according to
Jackson and Mantsch [41].
Circular Dichroism Analysis of the Wild-Type and Mutant
ACP6-TE Didomains
Far-UV CD spectra of the wild-type and mutant proteins, as well as
the temperature-dependent melting profiles, were obtained by using
an Aviv Circular Dichroism Spectrometer Model 215. Protein con-
centrations werew0.2 mg/ml, and far-UV spectra were acquired be-
tween 260 and 180 nm with a bandwidth of 0.5 nm. For thermal sta-
bility experiments, the CD signal at 222 nm was monitored at 1ºC
intervals from 25ºC to 80ºC. The exact concentrations of the protein
samples were obtained by amino acid analysis, and then used to
convert the background-subtracted CD spectra into molar ellipticity.
Deconvolution of the spectra was carried out on the Dichroweb site
[43] by using the analysis packages Selcon3 and CDSSTR [42] and
both reference sets 3 and 6. These data were then used to calculate
the average values and standard deviations for the percentages of
a helices and b sheets in the wild-type and mutant proteins.
Determination of Conditions for the Phosphopantetheinyl
Transfer Assay
The rates of phosphopantetheinylation of ACP6-TE and the R45V
mutant were determined at concentrations of 1.5, 3.1, 5.4, and 10
mM. To ensure that the total volume of substrate added to the assays
was constant, the 5.4 and 10 mM concentrations were obtained from
concentrated (43) stocks of ACP6-TE and R45V. Assay mixtures
containing the ACP6-TE and R45V in buffer [21, 22] (NaPi [50 mM;
pH 6 for Sfp or pH 7 for SePptII], MgCl2 [10 mM], DTT [5 mM], CoASH
[1 mM]) were prepared in a total volume of 300 ml, and the reactions
were initiated by the addition of either SePptII (3.1 nM) or Sfp (31
nM). Aliquots (100 ml) were removed at 2.5, 4.5, and 6.5 min and
quenched by the addition of 4 ml glacial acetic acid. To determine
the end point of the phosphopantetheinylation transfer reaction in
each case, identical assays (100 ml) were carried out for 2 hr and
then quenched with acetic acid. All of the quenched samples were
snap frozen in liquid nitrogen and stored at 280ºC until analyzed
by HPLC-MS (see above). The percentage of holo protein at eachtime point was obtained from the relative peak heights for the apo
and holo species, as assigned by their relative masses, and cor-
rected for the final extent of phosphopantetheinylation, if necessary.
The data were then used to derive an initial rate of reaction by linear
regression (Microsoft Excel).
Phosphopantetheinyl Transfer Assays
Assay mixtures containing the ACP6-TE and all mutants at a concen-
tration of 3.1 mM in buffer [21, 22] (NaPi [50 mM; pH 6 for Sfp or pH 7
for SePptII], MgCl2 [10 mM], DTT [5 mM], CoASH [1 mM]) were pre-
pared in a total volume of 300 ml, and the reactions were initiated
by the addition of either SePptII (3.1 nM) or Sfp (15.5 or 31 nM in
a particular set of assays). As the substrates were not eluted from
the Ni-NTA resin at identical concentrations as determined by Brad-
ford assay and amino acid analysis, differences in the volumes of
protein added to the assays were equalized by the addition of
pure elution buffer. Aliquots (100 ml) were removed at three time
points within the linear portion of each reaction (determined during
preliminary studies) and were quenched by the addition of 4 ml gla-
cial acetic acid. In every case, an identical reaction (100 ml) was car-
ried out in parallel to determine the final extent of modification (L39A
and R45E for 6 hr; 2 hr for all other mutants). All of the quenched
samples were snap frozen in liquid nitrogen and stored at280ºC un-
til they were analyzed by HPLC-MS (see above). The percentage of
holo protein at each time point was obtained from the relative peak
heights for the apo and holo species, as assigned by their relative
masses, and corrected for the final extent of phosphopantetheinyla-
tion, if necessary. The data were then used to derive an initial rate of
reaction for the wild-type ACP6-TE and each mutant by linear regres-
sion (Microsoft Excel). The combined results from multiple initial rate
determinations (at least two, but usually three) were used to derive
an average rate of phosphopantetheinylation for each mutant, which
was then compared to the average rate of reaction of the wild-type
protein (Table 1).
Supplemental Data
Supplemental Data include an alignment of representative PKS
ACP domains and are available at http://www.chembiol.com/cgi/
content/full/13/6/625/DC1/.
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